Literature DB >> 20149966

Synthesis, metabolism and in vitro cytotoxicity studies on novel lavendamycin antitumor agents.

Wen Cai1, Mary Hassani, Rajesh Karki, Ervin D Walter, Katherine H Koelsch, Hassan Seradj, Jayana P Lineswala, Hamid Mirzaei, Jeremy S York, Fatemeh Olang, Minoo Sedighi, Jennifer S Lucas, Thomas J Eads, Anthony S Rose, Sahba Charkhzarrin, Nicholas G Hermann, Howard D Beall, Mohammad Behforouz.   

Abstract

A series of lavendamycin analogues with two, three or four substituents at the C-6, C-7 N, C-2', C-3' and C-11' positions were synthesized via short and efficient methods and evaluated as potential NAD(P)H:quinone oxidoreductase (NQO1)-directed antitumor agents. The compounds were prepared through Pictet-Spengler condensation of the desired 2-formylquinoline-5,8-diones with the required tryptophans followed by further needed transformations. Metabolism and toxicity studies demonstrated that the best substrates for NQO1 were also the most selectively toxic to NQO1-rich tumor cells compared to NQO1-deficient tumor cells. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20149966      PMCID: PMC2841014          DOI: 10.1016/j.bmc.2010.01.037

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  23 in total

1.  Clinical observations on the effects of streptonigrin in patients with neoplastic disease.

Authors:  C A HACKETHAL; R B GOLBEY; C T TAN; D A KARNOFSKY; J H BURCHENAL
Journal:  Antibiot Chemother (Northfield)       Date:  1961-03

Review 2.  NAD(P)H:quinone oxidoreductase 1 (NQO1): chemoprotection, bioactivation, gene regulation and genetic polymorphisms.

Authors:  D Ross; J K Kepa; S L Winski; H D Beall; A Anwar; D Siegel
Journal:  Chem Biol Interact       Date:  2000-12-01       Impact factor: 5.192

3.  Isolation of lavendamycin, a new antibiotic from Streptomyces lavendulae.

Authors:  D M Balitz; J A Bush; W T Bradner; T W Doyle; F A O'Herron; D E Nettleton
Journal:  J Antibiot (Tokyo)       Date:  1982-03       Impact factor: 2.649

4.  Indolequinone antitumor agents: correlation between quinone structure and rate of metabolism by recombinant human NAD(P)H:quinone oxidoreductase. Part 2.

Authors:  E Swann; P Barraja; A M Oberlander; W T Gardipee; A R Hudnott; H D Beall; C J Moody
Journal:  J Med Chem       Date:  2001-09-27       Impact factor: 7.446

5.  Indolequinone antitumor agents: correlation between quinone structure, rate of metabolism by recombinant human NAD(P)H:quinone oxidoreductase, and in vitro cytotoxicity.

Authors:  H D Beall; S Winski; E Swann; A R Hudnott; A S Cotterill; N O'Sullivan; S J Green; R Bien; D Siegel; D Ross; C J Moody
Journal:  J Med Chem       Date:  1998-11-19       Impact factor: 7.446

6.  Novel lavendamycin analogues as potent HIV-reverse transcriptase inhibitors: synthesis and evaluation of anti-reverse transcriptase activity of amide and ester analogues of lavendamycin.

Authors:  Mohammad Behforouz; Wen Cai; Mark G Stocksdale; Jennifer S Lucas; Joo Yong Jung; Daniel Briere; Aiqin Wang; Kevin S Katen; Nancy C Behforouz
Journal:  J Med Chem       Date:  2003-12-18       Impact factor: 7.446

7.  Cytosolic NAD(P)H:(quinone-acceptor)oxidoreductase in human normal and tumor tissue: effects of cigarette smoking and alcohol.

Authors:  J J Schlager; G Powis
Journal:  Int J Cancer       Date:  1990-03-15       Impact factor: 7.396

8.  Factors affecting sensitivity to EO9 in rodent and human tumour cells in vitro: DT-diaphorase activity and hypoxia.

Authors:  N Robertson; A Haigh; G E Adams; I J Stratford
Journal:  Eur J Cancer       Date:  1994       Impact factor: 9.162

9.  DT-diaphorase protects cells from the hypoxic cytotoxicity of indoloquinone EO9.

Authors:  J A Plumb; M Gerritsen; P Workman
Journal:  Br J Cancer       Date:  1994-12       Impact factor: 7.640

10.  Immunological quantitation of DT-diaphorase in carcinoma cell lines and clinical colon cancers: advanced tumors express greater levels of DT-diaphorase.

Authors:  K Mikami; M Naito; T Ishiguro; H Yano; A Tomida; T Yamada; N Tanaka; T Shirakusa; T Tsuruo
Journal:  Jpn J Cancer Res       Date:  1998-09
View more
  6 in total

1.  Synthesis of 8-hydroxyquinoline derivatives as novel antitumor agents.

Authors:  Sau Hing Chan; Chung Hin Chui; Shun Wan Chan; Stanton Hon Lun Kok; Dessy Chan; Miriam Yuen Tung Tsoi; Polly Hang Mei Leung; Alfred King Yin Lam; Albert Sun Chi Chan; Kim Hung Lam; Johnny Cheuk On Tang
Journal:  ACS Med Chem Lett       Date:  2012-12-20       Impact factor: 4.345

2.  Synthesis and cytotoxic activities of some 2-arylnaphtho[2,3-d]oxazole-4,9-dione derivatives on androgen-dependent (LNCaP) and androgen-independent (PC3) human prostate cancer cell lines.

Authors:  Yakini Brandy; Innocent Ononiwu; Dolapo Adedeji; Vonetta Williams; Claudia Mouamba; Yasmine Kanaan; Robert L Copeland; Dwayne A Wright; Ray J Butcher; Samuel R Denmeade; Oladapo Bakare
Journal:  Invest New Drugs       Date:  2011-01-18       Impact factor: 3.850

3.  Synthesis of new quinolinequinone derivatives and preliminary exploration of their cytotoxic properties.

Authors:  Charles M Keyari; Alison K Kearns; Nathan S Duncan; Emily A Eickholt; Geoffrey Abbott; Howard D Beall; Philippe Diaz
Journal:  J Med Chem       Date:  2013-05-01       Impact factor: 7.446

Review 4.  5,8-Quinolinedione Scaffold as a Promising Moiety of Bioactive Agents.

Authors:  Monika Kadela-Tomanek; Ewa Bębenek; Elwira Chrobak; Stanisław Boryczka
Journal:  Molecules       Date:  2019-11-14       Impact factor: 4.411

Review 5.  Biological activities of polypyridyl-type ligands: implications for bioinorganic chemistry and light-activated metal complexes.

Authors:  Austin C Hachey; Dmytro Havrylyuk; Edith C Glazer
Journal:  Curr Opin Chem Biol       Date:  2021-03-30       Impact factor: 8.822

6.  Synthesis and characterization of novel unsymmetrical and symmetrical 3-halo- or 3-methoxy-substituted 2-dibenzoylamino-1,4-naphthoquinone derivatives.

Authors:  Yakini Brandy; Nailah Brandy; Emmanuel Akinboye; Malik Lewis; Claudia Mouamba; Seshat Mack; Ray J Butcher; Alan J Anderson; Oladapo Bakare
Journal:  Molecules       Date:  2013-02-04       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.